NCT05853003 is a clinical trial in Optic Neuropathy, sponsored by Amira M elSonbaty.

Who is sponsoring NCT05853003?

NCT05853003 is sponsored by Amira M elSonbaty.

What condition does NCT05853003 study?

NCT05853003 studies Optic Neuropathy.

Is NCT05853003 still recruiting?

NCT05853003 is currently completed. Last updated 3 July 2024.

Last reviewed 2024-07-03 · How we verify

NCT05853003

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuromuscular Ultrasonography Assessment of Optic Nerve in Systemic Lupus Eryhematosus

Completed Last updated 3 July 2024

What this trial tests

trial in Optic Neuropathy in 140 participants. Completed in 30 April 2023.

Timeline

1 January 2022

Primary endpoint
31 December 2022

30 April 2023

Quick facts

Lead sponsor	Amira M elSonbaty
Status	Completed
Study type	OBSERVATIONAL
Enrollment	140
Start date	1 January 2022
Primary completion	31 December 2022
Estimated completion	30 April 2023
Sites	1 location across Egypt

Conditions studied

Optic Neuropathy — all drugs for Optic Neuropathy →

Sponsor

Amira M elSonbaty

Who can join

17 and older, any sex, with Optic Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

assessing the role of neuromuscular ultrasound in optic nerve involvement in systemic lupus patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Optic Neuropathy

Currently open trials in the same condition.

NCT06662448 — Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05853003 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Amira M elSonbaty
Last refreshed: 3 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05853003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing